About the Authors

Graham H. Jackson

Contributed equally to this work with: Graham H. Jackson, Charlotte Pawlyn

Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing

graham.jackson@newcastle.ac.uk

Affiliation Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom

Charlotte Pawlyn

Contributed equally to this work with: Graham H. Jackson, Charlotte Pawlyn

Roles Conceptualization, Data curation, Formal analysis, Investigation, Resources, Visualization, Writing – original draft, Writing – review & editing

Affiliations The Institute of Cancer Research, London, United Kingdom, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

David A. Cairns

Roles Conceptualization, Data curation, Formal analysis, Investigation, Project administration, Resources, Visualization, Writing – original draft, Writing – review & editing

Affiliation Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

Ruth M. de Tute

Roles Investigation, Resources, Writing – review & editing

Affiliation Haematological Malignancy Diagnostic Service, St James’s University Hospital, Leeds, United Kingdom

Anna Hockaday

Roles Investigation, Project administration, Writing – review & editing

Affiliation Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

Corinne Collett

Roles Investigation, Project administration, Writing – review & editing

Affiliation Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

John R. Jones

Roles Investigation, Visualization, Writing – review & editing

Affiliation Kings College Hospital NHS Foundation Trust, London, United Kingdom

Bhuvan Kishore

Roles Investigation, Resources, Writing – review & editing

Affiliation University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Mamta Garg

Roles Investigation, Resources, Writing – review & editing

Affiliation Leicester Royal Infirmary, Leicester, United Kingdom

Cathy D. Williams

Roles Investigation, Resources, Writing – review & editing

Affiliation Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom

Kamaraj Karunanithi

Roles Investigation, Resources, Writing – review & editing

Affiliation University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom

Jindriska Lindsay

Roles Investigation, Resources, Writing – review & editing

Affiliation East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom

Alberto Rocci

Roles Investigation, Resources, Writing – review & editing

Affiliations Manchester University NHS Foundation Trust, Manchester, United Kingdom, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom

John A. Snowden

Roles Investigation, Resources, Writing – review & editing

Affiliation Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

Matthew W. Jenner

Roles Investigation, Resources, Writing – review & editing

Affiliation University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Gordon Cook

Roles Investigation, Resources, Writing – review & editing

Affiliations Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom, Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom

Nigel H. Russell

Roles Conceptualization, Funding acquisition, Resources, Writing – review & editing

Affiliation Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom

Mark T. Drayson

Roles Conceptualization, Data curation, Investigation, Resources, Writing – review & editing

Affiliation Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

Walter M. Gregory

Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Writing – review & editing

Affiliation Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

Martin F. Kaiser

Roles Data curation, Investigation, Resources, Writing – review & editing

Affiliations The Institute of Cancer Research, London, United Kingdom, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

Roger G. Owen

Roles Conceptualization, Data curation, Investigation, Resources, Writing – review & editing

Affiliation Haematological Malignancy Diagnostic Service, St James’s University Hospital, Leeds, United Kingdom

Faith E. Davies

Roles Conceptualization, Funding acquisition, Investigation, Resources, Writing – original draft, Writing – review & editing

‡ These authors are joint senior authors on this work.

Affiliation Perlmutter Cancer Center, NYU Langone Health, New York, New York, United States of America

Gareth J. Morgan

Roles Conceptualization, Funding acquisition, Investigation, Resources, Writing – original draft, Writing – review & editing

‡ These authors are joint senior authors on this work.

Affiliation Perlmutter Cancer Center, NYU Langone Health, New York, New York, United States of America

the UK NCRI Haemato-oncology Clinical Studies Group

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: RdeT and NR declare no conflict of interest. DAC, AH and CC, report research funding from Celgene Corporation, Amgen, and Merck Sharp and Dohme. GHJ has received consultancy fees, honoraria and speakers' bureau fees from Roche, Amgen, Janssen, and Merck Sharp and Dohme; and consultancy fees, honoraria, travel support, research funding, and speakers' bureau fees from Celgene Corporation and Takeda. CP has received consultancy fees, honoraria, and travel support from Amgen, Celgene Corporation, Janssen, Sanofi and Takeda Oncology. JRJ has received honoraria and research funding from Celgene Corporation. BK has received consultancy fees, travel support, and speakers' bureau fees from Celgene Corporation, Takeda, and Janssen. MG has received travel support, research funding, and speakers' bureau fees from Janssen; travel support from Takeda; and travel support and research funding from Novartis. CDW has received honoraria, travel support, and speakers' bureau fees from Takeda, Janssen, and Celgene Corporation; honoraria and speakers' bureau fees from Amgen; and honoraria from Novartis. KK has received travel support and research funding from Celgene Corporation and Janssen. JL has received consultancy fees from Janssen; travel support from Novartis and Takeda; consultancy fees and travel support from Bristol-Myers Squibb; and honoraria and travel support from Celgene Corporation. AR has received consultancy fees from Takeda and Sanofi Genzyme, honoraria from Celgene, Novartis, Takeda, Amgen, Janssen, travel support from AbbVie, Takeda and Janssen and has been part of advisory boards for Novartis, Janssen and Amgen. JAS has received speaker fees for educational events supported by Sanofi, Janssen, Jazz, Mallinckrodt, Actelion and Gilead and is a member of a trial IDMC for Kiadis Pharma. MWJ has received consultancy fees, honoraria, travel support, and research funding from Janssen; consultancy fees, honoraria, and travel support from Takeda and Amgen; consultancy fees, honoraria, and research funding from Celgene Corporation; and consultancy fees and honoraria from Novartis. GC has received consultancy fees, honoraria, research funding, and speakers' bureau fees from Takeda, Celgene Corporation, Janssen, and Amgen; consultancy fees and honoraria from Glycomimetics and Bristol-Myers Squibb; and consultancy fees, honoraria, and speakers' bureau fees from Sanofi. MTD has equity ownership in, and is on the board of directors and advisory committee of, Abingdon Health. WMG has received consultancy fees and research funding from Celgene Corporation; research funding from Amgen and Merck Sharp and Dohme; and honoraria from Janssen. MFK has received consultancy fees and travel support from Bristol-Myers Squibb and Takeda; consultancy fees from Chugai; consultancy fees and honoraria from Janssen and Amgen; and consultancy fees, honoraria, and research funding from Celgene Corporation. RGO has received honoraria and travel support from Takeda; consultancy fees and travel support from Janssen; consultancy fees, honoraria, and research funding from Celgene Corporation. FED has received consultancy fees and honoraria from Amgen, AbbVie, Takeda, Janssen, Celgene and Roche. GJM has received research funding from Janssen; consultancy fees and honoraria from Bristol-Myers Squibb, Roche, Amgen, GSK, Karyopharm and Takeda; and consultancy fees, honoraria, and research funding from Celgene Corporation.